Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Saccharomyces Cerevisiae for IBS Pain
NCT05149599Phase 2Completed
- Sponsor
- Ziauddin University
- Start
- Mar 2021
- Primary completion
- Oct 2021
- Modality
- Yeast Strains, Defined Consortia, Bacterial Strains
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of saccharomyces cerevisiae in irritable bowel syndrome (IBS), sponsored by Ziauddin University. Primary endpoint: Pain/Discomfort Score at 1 month. Started Mar 2021; status: completed.
02
Drugs
saccharomyces cerevisiae
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT05149599.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05149599.